Correlation Between Grifols SA and Pharma Mar

Can any of the company-specific risk be diversified away by investing in both Grifols SA and Pharma Mar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and Pharma Mar into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Grifols SA and Pharma Mar SA, you can compare the effects of market volatilities on Grifols SA and Pharma Mar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of Pharma Mar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and Pharma Mar.

Diversification Opportunities for Grifols SA and Pharma Mar

0.36

Correlation Coefficient

Grifols SA  Pharma Mar

Weak diversification

The 3 months correlation between Grifols and Pharma is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA and Pharma Mar SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Mar SA and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA are associated (or correlated) with Pharma Mar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Mar SA has no effect on the direction of Grifols SA i.e., Grifols SA and Pharma Mar go up and down completely randomly.

Pair Corralation between Grifols SA and Pharma Mar

Assuming the 90 days trading horizon Grifols SA is expected to under-perform the Pharma Mar. But the stock apears to be less risky and, when comparing its historical volatility, Grifols SA is 1.02 times less risky than Pharma Mar. The stock trades about -0.03 of its potential returns per unit of risk. The Pharma Mar SA is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  7,690  in Pharma Mar SA on December 30, 2024 and sell it today you would earn a total of  630.00  from holding Pharma Mar SA or generate 8.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Grifols SA  vs.  Pharma Mar SA

Grifols SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Grifols SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Grifols SA is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pharma Mar SA

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Mar SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Pharma Mar may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Grifols SA and Pharma Mar

The main advantage of trading using opposite Grifols SA and Pharma Mar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, Pharma Mar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Mar will offset losses from the drop in Pharma Mar's long position.

The idea behind Grifols SA and Pharma Mar SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.